Keasling to Receive 2017 Amgen Biochemical and Molecular Engineering Award

JBEI’s CEO Jay Keasling has been selected as the 2017 recipient of the Amgen Biochemical and Molecular Engineering award, to be presented July 19 at the 20th Conference on Biochemical and Molecular Engineering in Newport Beach, Calif. The award, given in memory of metabolic engineering pioneer James E. “Jay” Bailey, recognizes research excellence and leadership.